Back to results
US 2020/0347107 A1Published application
Pacap stabilized peptide
AssigneeSenju Pharmaceutical Co., Ltd.
InventorsShinnosuke MACHIDA, Takeshi NAKAJIMA
Life of this patent
Estimating the term…
Abstract
The purpose of the present invention is to provide a PACAP peptide having increased stability. The problem is solved by the discovery that substituting a carboxy group of the position 3 and/or position 8 aspartic acid in the PACAP sequence by tetrazole significantly enhances stability.
Claims19
A peptide consisting of a sequence or modified sequence wherein, in the sequence represented by the following formula:
- (SEQ ID NO:
- 3)
- H-X1-D-G-I-F-T-D-X2-Y-X3-R-Y-R-X4-X5-X6-A-X7-X8-
- X9-Y-L-A-A-V-X10
- {where X1 is a neutral amino acid, X2 is a neutral amino acid, X3 is a neutral amino acid, X4 is a basic amino acid, X5 is a neutral amino acid or egTz, X6 is a non-polar amino acid, X7 is a non-polar amino acid, X8 is a basic amino acid, X9 is a basic amino acid and X10 is a neutral amino acid},
- the carboxy group of the aspartic acid residue at position 3 and/or position 8 is replaced with tetrazole, wherein the peptide binds to PAC1R, VPAC1R and VPACR2, and wherein the modified sequence is a sequence having a deletion or addition of one or more amino acids in the sequence of SEQ ID NO:
- 3.
4 more elements
Dependencies are inferred from the claim text.